Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Cyber Capital Founder: most Ether L2s are centralized and have the ability to transfer user funds without restriction

Cyber Capital Founder: most Ether L2s are centralized and have the ability to transfer user funds without restriction

Bitget2024/09/01 18:04

Justin Bons, founder and chief investment officer of European cryptocurrency fund Cyber Capital, has once again criticized the operation of Ether L2 solutions. In a recent X post on Saturday, Bons labeled these blockchain platforms, which are designed to increase the scalability of the Ether network, as dangerous because of their ability to move users' money without restriction. Justin Bons said that most major Ether L2 solutions are centralized, with a single server typically responsible for running the platform's operations. This design goes against Cypherhunk's principles of decentralization and security, and is harmful to investors because these chains could collapse at any time due to a single event, and could even be manipulated to steal users' funds.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.